Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
extension tags : Drug save search
NeoPhore raises an additional £9.6m (USD $12.2m) Series B financing extension to further progress drug discovery pipeline
Published: 2024-02-01 (Crawled : 09:00) - prnewswire.com
ALPMY | News | $9.49 -1.11% 480K
|
Manufacturing
|
| O: -0.86%
H: 3.34%
C: 0.43%
drug pipeline series extension
Optinose Announces 3-Month Extension of FDA Review Period for the Supplemental New Drug Application for XHANCE
Published: 2023-12-06 (Crawled : 12:00) - globenewswire.com
OPTN | $0.92 -4.93% -5.18% 570K
|
Health Services
|
| O: -17.01%
H: 1.64%
C: 0.82%
fda xhance drug review extension application
Kadcyla Leads the Global Antibody Drug Conjugates Market with Extensive Use in Breast Cancer Treatment
Published: 2023-11-01 (Crawled : 18:00) - prnewswire.com
ALPMY | News | $9.49 -1.11% 480K
|
Manufacturing
|
| O: -1.46%
H: 3.67%
C: 3.26%
ZYME | $8.555 -0.06% -0.06% 590K
|
Health Technology
|
| O: 1.14%
H: 0.42%
C: -0.7%
TAK | News | $13.23 -1.12% 0.0% 920K
|
Health Technology
|
| O: 1.03%
H: 0.73%
C: 0.58%
ADCT | $4.78 -3.82% 0.0% 280K
|
Health Technology
|
| O: -0.16%
H: 6.42%
C: 4.49%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: -0.86%
H: 0.0%
C: 0.0%
STRO | $3.47 -6.72% -7.2% 540K
|
Health Technology
|
| O: 0.39%
H: 3.86%
C: 3.86%
IMGN | News | $31.23 0.03% 49M
|
Health Technology
|
| O: 5.09%
H: 5.48%
C: -1.27%
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: -0.47%
H: 1.88%
C: 1.78%
EXEL | $23.7 1.76% 1.73% 1.5M
|
Health Technology
|
| O: -2.62%
H: 1.17%
C: -1.66%
drug antibody breast cancer treatment global market
Biogen Announces FDA’s 3-Month Extension of Review Period for the New Drug Application for Tofersen
Published: 2022-10-17 (Crawled : 12:00) - globenewswire.com
IONS | $42.455 1.47% 1.45% 730K
|
Health Technology
|
| O: 0.97%
H: 1.62%
C: -0.62%
BIIB | $201.91 4.52% 4.32% 3.3M
|
Health Technology
|
| O: 0.54%
H: 2.99%
C: 1.32%
drug extension application review
PsychoGenics Announces Extension of Ongoing Drug Discovery Collaboration with Karuna Therapeutics
Published: 2022-10-11 (Crawled : 13:20) - biospace.com/
KRTX | $329.83 0.0% 1.9M
|
Health Technology
|
| O: -0.12%
H: 2.69%
C: -0.3%
ongoing drug collaboration extension therapeutics
Reata Pharmaceuticals Announces Three Month Extension of the Review Period for New Drug Application for Omaveloxolone for the Treatment of Friedreich’s Ataxia
Published: 2022-08-09 (Crawled : 11:00) - biospace.com/
RETA | $172.36 0.02% 0.03% 0
|
Health Technology
|
| O: -1.21%
H: 0.13%
C: -10.18%
treatment drug extension application review friedreich’s ataxia
Alnylam Announces 3-Month Extension of Review Period for New Drug Application for Vutrisiran
Published: 2022-04-04 (Crawled : 12:00) - biospace.com/
ALNY | $143.8 -1.55% -1.58% 390K
|
Health Technology
|
| O: -1.2%
H: 0.26%
C: -3.28%
drug application review
Concert Pharmaceuticals Presents Update on CTP-543 Long-Term Extension Study in Alopecia Areata During 2nd JAK Inhibitors Drug Development Summit
Published: 2021-07-01 (Crawled : 12:00) - biospace.com/
CNCE | $8.37 0.36% 0
|
Health Technology
|
| O: 0.24%
H: 0.0%
C: -4.02%
drug
Ascendis Pharma A/S Announces Extension of U.S. Food and Drug Administration Review Period for TransCon™ hGH
Published: 2021-06-11 (Crawled : 00:20) - biospace.com/
ASND | $143.14 -1.17% -1.18% 230K
|
Health Technology
|
| O: -0.67%
H: 2.33%
C: 2.27%
food drug pharma
Ascendis Pharma A/S Announces Extension of U.S. Food and Drug Administration Review Period for TransCon™ hGH (Lonapegsomatropin) for Pediatric Growth Hormone Deficiency
Published: 2021-06-11 (Crawled : 22:00) - globenewswire.com
ASND | $143.14 -1.17% -1.18% 230K
|
Health Technology
| Email alert
Add to watchlist
food growth hormone drug growth hormone
Relay Therapeutics Strengthens Computational Leadership Team with Addition of Patrick Riley, Ph.D.Dr. Riley brings extensive experience in artificial intelligence with a focus on drug discovery
Published: 2021-05-10 (Crawled : 12:00) - biospace.com/
RLAY | $6.34 7.46% 6.94% 1.7M
|
Health Technology
|
| O: -0.68%
H: 0.61%
C: -5.43%
artificial intelligence computational drug discovery drug
Pfizer Announces Extension of Review of New Drug Application of Abrocitinib for the Treatment of Moderate to Severe Atopic Dermatitis
Published: 2021-04-07 (Crawled : 12:00) - biospace.com/
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: -0.06%
H: 0.58%
C: -0.33%
new drug treatment dermatitis drug atopic dermatitis application
Lilly and Incyte communicate review extension of supplemental New Drug Application for baricitinib for the treatment of moderate to severe atopic dermatitis
Published: 2021-04-06 (Crawled : 23:00) - biospace.com/
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: -0.11%
H: 0.51%
C: -1.02%
INCY | $51.72 0.14% 0.14% 1.5M
|
Health Technology
|
| O: -0.3%
H: 1.07%
C: 0.22%
new drug treatment dermatitis drug baricitinib atopic dermatitis
AbbVie Announces Extension of Review for Supplemental New Drug Application of Upadacitinib for the Treatment of Moderate to Severe Atopic Dermatitis
Published: 2021-04-02 (Crawled : 22:00) - prnewswire.com
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
| Email alert
Add to watchlist
new drug treatment dermatitis drug atopic dermatitis
Global GMP Cytokines Market Forecast Report 2021-2027: Extensive Pipeline of Drug Candidates for Cytokines Therapeutics & Utilization of Cytokines as Biomarkers
Published: 2021-03-18 (Crawled : 14:30) - prnewswire.com
TECH | $63.48 -0.33% -0.33% 980K
|
Health Technology
|
| O: -0.69%
H: 2.29%
C: -1.37%
drug biomarkers
AbbVie Announces Extension of Review for Supplemental New Drug Application of Upadacitinib for the Treatment of Adults with Active Psoriatic Arthritis
Published: 2021-03-17 (Crawled : 13:00) - prnewswire.com
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: -6.39%
H: 1.28%
C: 1.23%
new drug treatment drug
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.